Transcript
A (0:00)
This message is brought to you by Abercrombie and Fitch. I've been ready for summer for a while and now it's finally time for summer outfits. With a trip coming up, the A and F Vacation Shop has me covered. Abercrombie really knows how to do a lightweight outfit. Their tees, sweater, polos and linen blend shorts never miss. I wear Abercrombie denim year round. Their shorts are no different and have the comfort I need for summer prep. For your next trip with the A and F Vacation Shop, get their newest arrivals in store, online and in the app.
B (0:31)
Here's your TM welcome to BNB Tech Minute for Monday, May 19th. I'm Victoria Craig for the Wall Street Journal. As tariffs threaten to upend global supply chains, US Chip giant Nvidia is leaning into local partnerships with Foxconn and TSMC to build Taiwan's first AI supercomputer. Nvidia said Foxconn will provide the AI infrastructure, while TSMC researchers will use that system to advance R and D. Nvidia CEO Jensen Huang described Taiwan as a nexus for AI advancement and said his company is planning to build a new hub there. Nvidia also said it's opening its server platform to allow other companies to build semi custom AI infrastructure, and it announced expanded partnerships with Acer and Asus to make new high performance desktop supercomputers. Elsewhere, Chinese tech giant Xiaomi is working to make itself more self sufficient in the semiconductor industry as US China trade tensions simmer. In a social media post today, the company's founder and CEO said it would invest $7 billion in CH design over the next decade. Xiaomi is also expected to introduce a 3 nanometer mobile chip this week, which Chinese state TV declared as a breakthrough in Chinese chip Design. And finally, 23andMe will live on inside biotech company Regeneron, which has agreed to buy the beleaguered DNA testing company out of bankruptcy. The $256 million price tag is a steep fall from the $6 billion peak valuation that 23andMe achieved in 2021. Regeneron plans to continue operating its DNA testing business and use its database of roughly 15 million DNA samples to discover new drugs. For a deeper dive into what's happening in tech, check out Tuesday's Tech News Briefing podcast.
